TuHURA Biosciences, Inc./NV (HURA) › Shareholders' EquityTuHURA Biosciences, Inc./NV (HURA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $02010: -$1.5K2011: -$877.1K2012: -$1.33M2013: -$818.0K2014: -$901.2K2015: -$821.5K2016: $4.86M2017: $6.58M2018: $5.44M2019: $1.97M2020: $263.0K2021: $10.58M2022: $12.30M2023: -$1.56M2024: $14.59M2025: $20.93M$20.93M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$20.93M+43.4%2024$14.59M+1036.3%2023-$1.56M-112.7%2022$12.30M+16.3%2021$10.58M+3923.2%2020$263.0K-86.6%2019$1.97M-63.8%2018$5.44M-17.4%2017$6.58M+35.4%2016$4.86M+691.5%2015-$821.5K+8.8%2014-$901.2K-10.2%2013-$818.0K+38.4%2012-$1.33M-51.4%2011-$877.1K-57758.4%2010-$1.5K—2009$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share